Collectively, the findings obtained in our study may provide experimental evidence for the involvement of the PRKCE/AURKB/RAB27B axis in the resistance of breast cancer cells to PTX and offer a potential intervention target for reversing tumor drug resistance. The gene discussed is AURKB; the disease is neoplasm.